Brian A. Chauder

1.2k citations

23 papers · 928 indexed · h-index 16

Impact in

Organic Chemistry top 5%
- Catalytic C–H Functionalization Methods
Molecular Biology
- Ion channel regulation and function
- Receptor Mechanisms and Signaling
- Cell death mechanisms and regulation
- Protein Degradation and Inhibitors

Papers in

Organic Chemistry 14
- Coordination Chemistry and Organometallics 7
- Asymmetric Synthesis and Catalysis 4
- Synthetic Organic Chemistry Methods 3
Virology 2

Co-authors: Victor Snieckus Stephen W. Fesik А. В. Калинин Gautam Bhave Jerod S. Denton Edward T. OlejniczakBin ZhaoJason P. Burke
Journals: Journal of Medicinal Chemistry (4 papers)Molecular Pharmacology (3 papers)Organic Letters (2 papers)Journal of Clinical Oncology (2 papers)Synthesis (2 papers)
Partner nations: United States Canada Australia

In The Last Decade

Brian A. Chauder

23 papers receiving 903 citations

Peers

Countries citing papers authored by Brian A. Chauder

Since Specialization

Citations

This map shows the geographic impact of Brian A. Chauder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Chauder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Chauder more than expected).

Fields of papers citing papers by Brian A. Chauder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Chauder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Chauder. The network helps show where Brian A. Chauder may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian A. Chauder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian A. Chauder Line = papers co-authored together Brian A. Chauder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A randomized phase 2 study of an individualized neoantigen-targeting immunotherapy in patients with newly diagnosed metastatic microsatellite stable colorectal cancer (MSS-CRC). Journal of Clinical Oncology ·J. Randolph Hecht, Alexander I. Spira, Anthony V. Nguyen, Lyudmyla Berim, Alexander Starodub, Meredith Pelster, David Gallinson, Anup Kasi, Matthew J. Reilley, L. Hauschild, Ki Yong Chung, سامان فرامرزی, Brian A. Chauder, Kyounghwa Bae, Dennis W. Schneck, Andrew R. Allen, Karin Jooss, Andrew R. Ferguson, J. Thaddeus Beck	2025	3
2	Phase 2/3, randomized, open-label study of an individualized neoantigen vaccine (self-amplifying mRNA and adenoviral vectors) plus immune checkpoint blockade as maintenance for patients with newly diagnosed metastatic colorectal cancer (GRANITE). Journal of Clinical Oncology ·J. Randolph Hecht, Ardaman Shergill, В. И. Пудов, Bruno Fang, Amparo Climent-Richart, Heinz‐Josef Lenz, Lyudmyla Berim, Paul E. Oberstein, Rachael A. Safyan, محمود هاشم عبد القادر, Heloisa P. Soares, David R. Spigel, Alexander I. Spira, Andrew R. Ferguson, Brian A. Chauder, Alexander Starodub	2022	12
3	Fragment-Based Screening of the Bromodomain of ATAD2 Journal of Medicinal Chemistry ·Yolanda Banks, Brian A. Chauder, Jason Phan, Stephen W. Fesik	2014	64
4	Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor Bioorganic & Medicinal Chemistry Letters ·Bruce J. Melancon, Rocco D. Gogliotti, James C. Tarr, Arayombo Arayemi Serah, Brian A. Chauder, Evan P. Lebois, Hyekyung P. Cho, Thomas J. Utley, Douglas J. Sheffler, Thomas M. Bridges, Ryan D. Morrison, J. Scott Daniels, Colleen M. Niswender, P. Jeffrey Conn, Craig W. Lindsley, Michael R. Wood	2012	14
5	Discovery of 2‐(2‐Benzoxazoyl amino)‐4‐Aryl‐5‐Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu₅): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound ChemMedChem ·Ralf Mueller, Eric S. Dawson, Jens Meiler, Alice L. Rodriguez, Brian A. Chauder, 木下和也, Andrew S. Felts, Sarah Zimskind, Usha N. Menon, LongQing, In Gwan Kim, Carrie K. Jones, Karen J. Gregory, Colleen M. Niswender, P. Jeffrey Conn, Christopher M. Olsen, Danny G. Winder, Kyle A. Emmitte, Craig W. Lindsley	2012	40
6	Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design Journal of Medicinal Chemistry ·Anders Friberg, Dominico Vigil, Bin Zhao, R. Nathan Daniels, Jason P. Burke, Pedro M. García-Barrantes, DeMarco V. Camper, Brian A. Chauder, Taekyu Lee, Edward T. Olejniczak, Stephen W. Fesik	2012	232
7	Investigating Metabotropic Glutamate Receptor 5 Allosteric Modulator Cooperativity, Affinity, and Agonism: Enriching Structure-Function Studies and Structure-Activity Relationships Molecular Pharmacology ·Karen J. Gregory, Meredith J. Noetzel, Jerri M. Rook, Paige N. Vinson, Shaun R. Stauffer, Alice L. Rodriguez, Kyle A. Emmitte, Ya Zhou, Afaq Rzayeva, Andrew S. Felts, Brian A. Chauder, Craig W. Lindsley, Colleen M. Niswender, P. Jeffrey Conn	2012	70
8	Novel 4,4-Disubstituted Piperidine-Based C–C Chemokine Receptor-5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved human Ether-a-go-go Related Gene (hERG) Profile Journal of Medicinal Chemistry ·Wieslaw M. Kazmierski, Don L. Anderson, Christopher Aquino, Brian A. Chauder, Maosheng Duan, Robert G. Ferris, Terrence Kenakin, Cecilia S. Koble, Sharl Kendall, Maggie S. McIntyre, J. Piñas Massó, Christian Watson, Pat Wheelan, Andrew Spaltenstein, Mary Beth Wire, Angilique Svolto, E. Ejiri	2011	21
9	Development of a Selective Small-Molecule Inhibitor of Kir1.1, the Renal Outer Medullary Potassium Channel Molecular Pharmacology ·Gautam Bhave, Brian A. Chauder, Wen Liu, Eric S. Dawson, Rishin J. Kadakia, Thuy Thi Thanh Nguyen, L. Michelle Lewis, Jens Meiler, C. David Weaver, Lisa M. Satlin, Craig W. Lindsley, Jerod S. Denton	2010	63
10	Discovery of a small molecule inhibitor of ROMK and Kir7.1 Jerod S. Denton, C. David Weaver, L. Michelle Lewis, Brian A. Chauder, Craig W. Lindsley	2010	2
11	Small-Molecule Modulators of Inward Rectifier K⁺Channels: Recent Advances and Future Possibilities Future Medicinal Chemistry ·Gautam Bhave, Evelise Boliani, Brian A. Chauder, Jerod S. Denton	2010	42
12	High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1 Molecular Pharmacology ·L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, О Е Русинова, T Barrett, A. V. Polozhij, Malsete Aristides Santana, Craig W. Lindsley, C. David Weaver, Jerod S. Denton	2009	71
13	Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1 Journal of Medicinal Chemistry ·Wieslaw M. Kazmierski, Christopher Aquino, Brian A. Chauder, Felix Deanda, Robert G. Ferris, Michael Stoldt, Terrence Kenakin, Cecilia S. Koble, Christian Watson, Pat Wheelan, Hanbiao Yang, E. Ejiri	2008	26
14	seco-C/D Ring Analogues of Ergot Alkaloids. Synthesis via Intramolecular Heck and Ring-Closing Metathesis Reactions Organic Letters ·А. В. Калинин, Brian A. Chauder, Suman Rakhit, Victor Snieckus	2003	30
15	Directed Metalation Linked to Transition Metal Catalyzed Cascade Reactions: Two Total Syntheses of Plicadin, the Alleged Coumestan fromPsoralea plicata Angewandte Chemie International Edition ·Brian A. Chauder, А. В. Калинин, Nicholas J. Taylor, Victor Snieckus	1999	48
16	The directed ortho metalation–transition metal–catalyzed reaction symbiosis in heteroaromatic synthesis Pure and Applied Chemistry ·Brian A. Chauder, Linwong Pinai, Victor Snieckus	1999	30
17	Zwei Totalsynthesen von Plicadin, dem mutmaßlichen Cumestan ausPsoralea plicata: Kombination von gezielten Metallierungen mit Übergangsmetall-katalysierten Kaskadenreaktionen Angewandte Chemie ·Brian A. Chauder, А. В. Калинин, Е Г Тульчина, Victor Snieckus	1999	11
18	The directed ortho metalation — Cross‐coupling symbiosis in heteroaromatic synthesis Journal of Heterocyclic Chemistry ·Linwong Pinai, Brian A. Chauder, Victor Snieckus	1999	32
19	Phenylboronic Acid-Mediated Synthesis of 2H-Chromenes Synthesis ·Brian A. Chauder, Cláudio C. Lopes, Rosângela S. C. Lopes, Alcides J. M. da Silva, Victor Snieckus	1998	46
20	ChemInform Abstract: Phenylboronic Acid Mediated Synthesis of 2H‐Chromenes ChemInform ·Brian A. Chauder, Cláudio C. Lopes, Rosângela S. C. Lopes, Alcides J. M. da Silva, Victor Snieckus	1998	2

About Brian A. Chauder

Brian A. Chauder is a scholar working on Organic Chemistry, Virology, Hematology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 928 indexed citations. Recurring topics across this work include Coordination Chemistry and Organometallics (7 papers), Ion channel regulation and function (5 papers), Asymmetric Synthesis and Catalysis (4 papers), Cardiac electrophysiology and arrhythmias (4 papers), Neuroscience and Neuropharmacology Research (3 papers), Synthetic Organic Chemistry Methods (3 papers), Receptor Mechanisms and Signaling (3 papers) and Synthesis of Organic Compounds (3 papers). The work is most often cited by research in Organic Chemistry (332 citations), Molecular Biology (596 citations), Cellular and Molecular Neuroscience (145 citations), Computational Theory and Mathematics (111 citations) and Toxicology (22 citations). Brian A. Chauder has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Victor Snieckus, Stephen W. Fesik, А. В. Калинин, Gautam Bhave, Jerod S. Denton, Edward T. Olejniczak, Bin Zhao, Jason P. Burke, Dominico Vigil and Taekyu Lee. Their work appears in journals such as Journal of Medicinal Chemistry, Molecular Pharmacology, Organic Letters, Journal of Clinical Oncology and Synthesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact